EUVIMEDEUVIMED entdecken
Crossref

CPNE1 modulates Parkinson’s disease risk through peripheral immune cell function: a cross-tissue and single-cell causal inference study

Jing Zhao, Jia Fu, Jingjing Zhang, Zhongchi Zhang, Xue Bai, Lifen Yao iD

Mammalian Genome · 2026-12 · 37 (1)

DOI: 10.1007/s00335-026-10236-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mammalian Genome, online erschienen am 11.05.2026. Verfasst von Jing Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Harbin Medical University, Harbin, 150080, Heilongjiang Province, China. Hauptthemen laut MEDLINE: Parkinson Disease, Genetic Predisposition to Disease. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Jing Zhao, the Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences, the Inner Mongolia Autonomous Region Science and Technology Planning Project, the Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It has been increasingly recognized that, to a significant extent, the peripheral immune system is playing a role in the etiology of Parkinson’s disease (PD). It has been reported recently that there may be multiple types of genetic susceptibility factors influencing the risk of PD through alterations in the functions of particular immune cells; at present, the precise mechanisms involved remain unclear. Based on a multi-dimensional causality inference model that included data from genome-wide association studies (GWAS), expression quantitative trait loci (eQTL), protein quantitative trait loci (pQTL) and single-cell eQTL (sc-eQTL), we performed both cross-tissue Mendelian randomization (MR) analysis and immune cell-specific MR analysis to investigate the association between genetic risk factors and peripheral immune functions based on individuals with PD. We found that the genetic prediction of CPNE1 expression had a negative association with PD risk in whole blood, substantia nigra and several immune cell types. The results support a possible protective relationship between CPNE1 and PD risk; however, the subsequent biological mechanism remains unclear. Genetically predicted CPNE1 expression showed a significant association with lower PD risk at the level of immune cells in nine different subtypes: T cells, monocytes, natural killer cells and so on. In addition, the exploratory immune-infiltration analysis of peripheral-blood transcriptomics data showed that there was a positive correlation of CPNE1 expression with the inferred number of regulatory T-cells; therefore, this result requires confirmation in subsequent studies. Our results suggest that CPNE1 could be a candidate factor for the reduced PD risk in blood, substantia nigra and several immune cell subsets. The above results suggest that peripheral immune regulation is likely associated with the link between CPNE1-relevant pathways and PD; however, it cannot determine the intermediate steps linking peripheral immune effects to neuroprotection in the brain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseGenetic Predisposition to DiseaseHumansQuantitative Trait LociGenome-Wide Association StudyPolymorphism, Single NucleotideRisk FactorsMendelian Randomization AnalysisSingle-Cell AnalysisSubstantia Nigra

Autor:innen und Institutionen

  • The First Affiliated Hospital of Harbin Medical University, Harbin, 150080, Heilongjiang Province, China.
  • Chifeng Municipal Hospital, Chifeng City, 024000, Inner Mongolia Autonomous Region, China.
  • Affiliated Chifeng Clinical Medical College of Inner Mongolia Medical University, Chifeng, Inner Mongolia, China.
  • Chifeng Municipal Hospital, Chifeng City, 024000, Inner Mongolia Autonomous Region, China. 1036516668@qq.com.
  • The First Affiliated Hospital of Harbin Medical University, Harbin, 150080, Heilongjiang Province, China. 600749@hrbmu.edu.cn.

ORCID-Profile: Lifen Yao

Förderung

  • Jing Zhao, the Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences
  • the Inner Mongolia Autonomous Region Science and Technology Planning Project
  • the Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences

Zitieren

APA

Zhao, J., Fu, J., Zhang, J., Zhang, Z., Bai, X., & Yao, L. (2026). CPNE1 modulates Parkinson’s disease risk through peripheral immune cell function: a cross-tissue and single-cell causal inference study. Mammalian Genome, 37(1). https://doi.org/10.1007/s00335-026-10236-1

Vancouver

Zhao J, Fu J, Zhang J, Zhang Z, Bai X, Yao L. CPNE1 modulates Parkinson’s disease risk through peripheral immune cell function: a cross-tissue and single-cell causal inference study. Mammalian Genome. 2026;37(1). doi:10.1007/s00335-026-10236-1

BibTeX
@article{Zhao2026,
  author = {Zhao, Jing and Fu, Jia and Zhang, Jingjing and Zhang, Zhongchi and Bai, Xue and Yao, Lifen},
  title = {CPNE1 modulates Parkinson’s disease risk through peripheral immune cell function: a cross-tissue and single-cell causal inference study},
  journal = {Mammalian Genome},
  year = {2026},
  volume = {37},
  number = {1},
  doi = {10.1007/s00335-026-10236-1}
}
Kostenlos starten →